Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Magen-Darm » Funktionelle Beschwerden 25. Januar 2020
Suchen
Gastroplattform
Funktionelle Beschwerden
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Diarrhoe
IBD (Crohn/Colitis)
Funktionelle Beschwerden
Gastroenteritis
GI-Blutung
Neoplasie
Peptisches Ulkus
Anderes
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 323  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 6455  
   
Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise-Searching for Gap Fillers in the Oxidative Stress Way of Thinking.
Medicina (Kaunas)
Balmus IM, Ilie-Dumitru O, Ciobica A, Cojocariu RO, Stanciu C, Trifan A, Cimpeanu M, Cimpeanu C, Gorgan L.
PMID: 31963795 [PubMed - in process]


A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
Dig Liver Dis
Sadrin S, Sennoune S, Gout B, Marque S, Moreau J, Zinoune K, Grillasca JP, Pons O, Maixent JM.
PMID: 31952938 [PubMed - as supplied by publisher]


Intestinal barrier function is maintained with aging - a comprehensive study in healthy subjects and irritable bowel syndrome patients.
Sci Rep
Wilms E, Troost FJ, Elizalde M, Winkens B, de Vos P, Mujagic Z, Jonkers DMAE, Masclee AAM.
PMID: 31949225 [PubMed - in process]


Sex as a biological variable in irritable bowel syndrome.
Neurogastroenterol Motil
Camilleri M.
PMID: 31943595 [PubMed - as supplied by publisher]


Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1).
Am J Gastroenterol
Chey WD, Lembo AJ, Rosenbaum DP.
PMID: 31934897 [PubMed - as supplied by publisher]


Stigma and irritable bowel syndrome: a taboo subject?
Lancet Gastroenterol Hepatol
Hearn M, Whorwell PJ, Vasant DH.
PMID: 31924568 [PubMed - as supplied by publisher]


The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial.
J Neurogastroenterol Motil
Shin SY, Cha BK, Kim WS, Park JY, Kim JW, Choi CH.
PMID: 31917916 [PubMed]


Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Am J Gastroenterol
Shah A, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MM, Morrison M, Holtmann GJ.
PMID: 31913194 [PubMed - as supplied by publisher]


Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.
Am J Gastroenterol
Shah ED, Almario CV, Spiegel BM, Chey WD.
PMID: 31913193 [PubMed - as supplied by publisher]


Healthy lifestyle score and irritable bowel syndrome: A cross-sectional study in adults.
Neurogastroenterol Motil
Hajishafiee M, Keshteli AH, Saneei P, Feinle-Bisset C, Esmaillzadeh A, Adibi P.
PMID: 31912611 [PubMed - as supplied by publisher]


Effectiveness of Two Dietary Approaches on the Quality of Life and Gastrointestinal Symptoms of Individuals with Irritable Bowel Syndrome.
J Clin Med
Guerreiro MM, Santos Z, Carolino E, Correa J, Cravo M, Augusto F, Chagas C, Guerreiro CS.
PMID: 31906563 [PubMed]


Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
Saudi J Gastroenterol
Sun JR, Kong CF, Qu XK, Deng C, Lou YN, Jia LQ.
PMID: 31898645 [PubMed - as supplied by publisher]


Treating irritable bowel syndrome through an interdisciplinary approach.
Ann Gastroenterol
Nelkowska DD.
PMID: 31892791 [PubMed]


Multicentre, non-interventional study of the efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in primary, secondary and tertiary centres: the Alpine study.
BMJ Open
Pohl D, Fried M, Lawrance D, Beck E, Hammer HF.
PMID: 31892640 [PubMed - in process]


Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome.
Gastroenterol Res Pract
Wang Y, Zheng F, Liu S, Luo H.
PMID: 31885549 [PubMed]


Serum patterns of mir-23a and mir-181b in irritable bowel syndrome and colorectal cancer - A pilot study.
Bosn J Basic Med Sci
Chira A, Muresan MS, Braicu C, Budisan L, Raduly L, Chira RI, Dumitrascu DL, Berindan-Neagoe I.
PMID: 31881168 [PubMed - as supplied by publisher]


The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial.
EBioMedicine
Johnsen PH, Hilpüsch F, Valle PC, Goll R.
PMID: 31877418 [PubMed - as supplied by publisher]


Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Lancet Gastroenterol Hepatol
Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC.
PMID: 31859183 [PubMed - in process]


Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
Gut
El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T.
PMID: 31852769 [PubMed - as supplied by publisher]





PMID: 31851439 [PubMed]


   
   Artikel 1 - 20 / 6455    Seite 1 von 323  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1